Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Hematology  |  Nephrology  |  Oncology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Blood Cancer Clinical Trials

A listing of Blood Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (722) clinical trials

The study will be divided into two parts: a "dose-escalation part" to evaluate safety profile and to explore the Maximum tolerated dose (MTD) and an "expansion part" to evaluate further the safety and tumor response profile of BAY1862864 Injection at the selected dose.

Phase

Patients should be in need of and fit for immunochemotherapy and should not be resistant to rituximab (resistance defined as lack of response, or progression within 6 months of the last course of treatment with a rituximab containing regimen). This study will be composed of two parts: Safety run-in and ...

Phase

This clinical trial is provided by Antidote. If you have a B-cell malignancy (leukemia or lymphoma) you may be eligible to take part in this clinical research study. We are looking for people with leukemia or lymphoma that has returned after initial successful treatment (relapsed) or hasn’t improved with treatment ...

Phase

A research study is evaluating blood samples collected from lung cancer and pulmonary nodule patients to assist in future diagnostic test development.

Phase N/A

This study is designed to evaluate progression-free survival for ACE-196 vs ibrutinib in previously treated chronic lymphocytic leukemia. Intervention: ACP-196 will be orally administered until disease progression or unacceptable toxicity. Ibrutinib will be orally administered until disease progression or unacceptable toxicity. Study Type: Interventional Study Design: Allocation: Randomized Intervention Model: ...

Phase

This clinical trial is provided by Antidote. People with Chronic Lymphocytic Leukemia (CLL) often require combinations of different therapies to treat their CLL. The drug obinutuzumab combined with the chemotherapy drug chlorambucil is an approved therapy for the treatment of CLL, however it may not be effective for all patients. ...

Phase